APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Budesonide (BUD)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Budesonide (BUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173973020321 December 2025194 pages

Choose your research edition.

Industry ResearchBudesonide (BUD) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide (BUD) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Budesonide (BUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide (BUD) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide (BUD) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Budesonide (BUD) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Budesonide (BUD) include Chiesi Farmaceutici, Cipla, Cosmo Pharmaceuticals, Dr. Falk Pharma, Lunan Better Pharmaceutical, Orion, Shanghai Sine Promod Pharmaceutical, Synmosa Biopharma and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Budesonide (BUD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Budesonide (BUD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Budesonide (BUD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Budesonide (BUD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Budesonide (BUD) Segment by Company

Chiesi Farmaceutici

Cipla

Cosmo Pharmaceuticals

Dr. Falk Pharma

Lunan Better Pharmaceutical

Orion

Shanghai Sine Promod Pharmaceutical

Synmosa Biopharma

AstraZeneca

Mylan

Sandoz

Teva

Budesonide (BUD) Segment by Type

Pill

Inhaler

Nasal Spray

Budesonide (BUD) Segment by Application

Nose Disease Treatment

Respiratory Disease Treatment

Inflammatory Bowel Disease Treatment

Budesonide (BUD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide (BUD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide (BUD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide (BUD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Budesonide (BUD) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Budesonide (BUD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Budesonide (BUD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Budesonide (BUD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Budesonide (BUD) Industry Trends Table 2. Budesonide (BUD) Industry Drivers Table 3. Budesonide (BUD) Industry Opportunities and Challenges Table 4. Budesonide (BUD) Industry Restraints Table 5. Global Budesonide (BUD) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Budesonide (BUD) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Budesonide (BUD) Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Budesonide (BUD) Sales Market Share by Manufacturers Table 9. Global Budesonide (BUD) Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Budesonide (BUD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Budesonide (BUD) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Budesonide (BUD) Manufacturers, Product Type & Application Table 13. Global Budesonide (BUD) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Budesonide (BUD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pill Table 17. Major Manufacturers of Inhaler Table 18. Major Manufacturers of Nasal Spray Table 19. Global Budesonide (BUD) Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global Budesonide (BUD) Sales by Type (2021-2026) & (k tons) Table 21. Global Budesonide (BUD) Sales by Type (2027-2032) & (k tons) Table 22. Global Budesonide (BUD) Sales Market Share by Type (2021-2026) Table 23. Global Budesonide (BUD) Sales Market Share by Type (2027-2032) Table 24. Global Budesonide (BUD) Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 25. Global Budesonide (BUD) Revenue by Type (2021-2026) & (k tons) Table 26. Global Budesonide (BUD) Revenue by Type (2027-2032) & (k tons) Table 27. Global Budesonide (BUD) Revenue Market Share by Type (2021-2026) Table 28. Global Budesonide (BUD) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Nose Disease Treatment Table 30. Major Manufacturers of Respiratory Disease Treatment Table 31. Major Manufacturers of Inflammatory Bowel Disease Treatment Table 32. Global Budesonide (BUD) Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global Budesonide (BUD) Sales by Application (2021-2026) & (k tons) Table 34. Global Budesonide (BUD) Sales by Application (2027-2032) & (k tons) Table 35. Global Budesonide (BUD) Sales Market Share by Application (2021-2026) Table 36. Global Budesonide (BUD) Sales Market Share by Application (2027-2032) Table 37. Global Budesonide (BUD) Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 38. Global Budesonide (BUD) Revenue by Application (2021-2026) & (k tons) Table 39. Global Budesonide (BUD) Revenue by Application (2027-2032) & (k tons) Table 40. Global Budesonide (BUD) Revenue Market Share by Application (2021-2026) Table 41. Global Budesonide (BUD) Revenue Market Share by Application (2027-2032) Table 42. Global Budesonide (BUD) Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global Budesonide (BUD) Sales by Region (2021-2026) & (k tons) Table 44. Global Budesonide (BUD) Sales Market Share by Region (2021-2026) Table 45. Global Budesonide (BUD) Sales Forecasted by Region (2027-2032) & (k tons) Table 46. Global Budesonide (BUD) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 48. North America Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 49. North America Budesonide (BUD) Sales by Country (2027-2032) & (k tons) Table 50. Europe Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. Europe Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 52. Europe Budesonide (BUD) Sales by Country (2027-2032) & (k tons) Table 53. Asia Pacific Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Asia Pacific Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 55. Asia Pacific Budesonide (BUD) Sales by Country (2027-2032) & (k tons) Table 56. South America, Middle East and Africa Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. South America, Middle East and Africa Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 58. South America, Middle East and Africa Budesonide (BUD) Sales by Country (2027-2032) & (k tons) Table 59. Global Budesonide (BUD) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Budesonide (BUD) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Budesonide (BUD) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Budesonide (BUD) Revenue Market Share by Region (2021-2026) Table 63. Global Budesonide (BUD) Revenue Market Share by Region (2027-2032) Table 64. Chiesi Farmaceutici Company Information Table 65. Chiesi Farmaceutici Business Overview Table 66. Chiesi Farmaceutici Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chiesi Farmaceutici Budesonide (BUD) Product Portfolio Table 68. Chiesi Farmaceutici Recent Development Table 69. Cipla Company Information Table 70. Cipla Business Overview Table 71. Cipla Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cipla Budesonide (BUD) Product Portfolio Table 73. Cipla Recent Development Table 74. Cosmo Pharmaceuticals Company Information Table 75. Cosmo Pharmaceuticals Business Overview Table 76. Cosmo Pharmaceuticals Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolio Table 78. Cosmo Pharmaceuticals Recent Development Table 79. Dr. Falk Pharma Company Information Table 80. Dr. Falk Pharma Business Overview Table 81. Dr. Falk Pharma Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Dr. Falk Pharma Budesonide (BUD) Product Portfolio Table 83. Dr. Falk Pharma Recent Development Table 84. Lunan Better Pharmaceutical Company Information Table 85. Lunan Better Pharmaceutical Business Overview Table 86. Lunan Better Pharmaceutical Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolio Table 88. Lunan Better Pharmaceutical Recent Development Table 89. Orion Company Information Table 90. Orion Business Overview Table 91. Orion Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Orion Budesonide (BUD) Product Portfolio Table 93. Orion Recent Development Table 94. Shanghai Sine Promod Pharmaceutical Company Information Table 95. Shanghai Sine Promod Pharmaceutical Business Overview Table 96. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolio Table 98. Shanghai Sine Promod Pharmaceutical Recent Development Table 99. Synmosa Biopharma Company Information Table 100. Synmosa Biopharma Business Overview Table 101. Synmosa Biopharma Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Synmosa Biopharma Budesonide (BUD) Product Portfolio Table 103. Synmosa Biopharma Recent Development Table 104. AstraZeneca Company Information Table 105. AstraZeneca Business Overview Table 106. AstraZeneca Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. AstraZeneca Budesonide (BUD) Product Portfolio Table 108. AstraZeneca Recent Development Table 109. Mylan Company Information Table 110. Mylan Business Overview Table 111. Mylan Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Mylan Budesonide (BUD) Product Portfolio Table 113. Mylan Recent Development Table 114. Sandoz Company Information Table 115. Sandoz Business Overview Table 116. Sandoz Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Sandoz Budesonide (BUD) Product Portfolio Table 118. Sandoz Recent Development Table 119. Teva Company Information Table 120. Teva Business Overview Table 121. Teva Budesonide (BUD) Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Teva Budesonide (BUD) Product Portfolio Table 123. Teva Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Budesonide (BUD) Distributors List Table 127. Budesonide (BUD) Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Budesonide (BUD) Product Image Figure 2. Global Budesonide (BUD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide (BUD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Budesonide (BUD) Sales (2021-2032) & (k tons) Figure 5. Global Budesonide (BUD) Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Budesonide (BUD) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pill Image Figure 9. Inhaler Image Figure 10. Nasal Spray Image Figure 11. Global Budesonide (BUD) Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global Budesonide (BUD) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Budesonide (BUD) Sales Market Share by Type (2021-2032) Figure 14. Global Budesonide (BUD) Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 15. Global Budesonide (BUD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Budesonide (BUD) Revenue Market Share by Type (2021-2032) Figure 17. Nose Disease Treatment Image Figure 18. Respiratory Disease Treatment Image Figure 19. Inflammatory Bowel Disease Treatment Image Figure 20. Global Budesonide (BUD) Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global Budesonide (BUD) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Budesonide (BUD) Sales Market Share by Application (2021-2032) Figure 23. Global Budesonide (BUD) Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Budesonide (BUD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Budesonide (BUD) Revenue Market Share by Application (2021-2032) Figure 26. North America Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 27. North America Budesonide (BUD) Sales Market Share by Country (2021-2032) Figure 28. U.S. Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Canada Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Mexico Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe Budesonide (BUD) Sales Market Share by Country (2021-2032) Figure 33. Germany Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 34. France Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 35. U.K. Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Italy Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Netherlands Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific Budesonide (BUD) Sales Market Share by Country (2021-2032) Figure 40. China Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Japan Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 42. South Korea Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Southeast Asia Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 44. India Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Australia Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa Budesonide (BUD) Sales Market Share by Country (2021-2032) Figure 48. Brazil Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South Africa Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Saudi Arabia Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Turkey Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Argentina Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 53. UAE Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Egypt Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Chile Budesonide (BUD) Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Global Budesonide (BUD) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Budesonide (BUD) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Budesonide (BUD) Revenue (2021-2032) & (US$ Million) Figure 59. North America Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Budesonide (BUD) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Budesonide (BUD) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Budesonide (BUD) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Budesonide (BUD) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Budesonide (BUD) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pill
  • Inhaler
  • Nasal Spray
Applications
  • Nose Disease Treatment
  • Respiratory Disease Treatment
  • Inflammatory Bowel Disease Treatment
Companies covered
  • Chiesi Farmaceutici
  • Cipla
  • Cosmo Pharmaceuticals
  • Dr. Falk Pharma
  • Lunan Better Pharmaceutical
  • Orion
  • Shanghai Sine Promod Pharmaceutical
  • Synmosa Biopharma
  • AstraZeneca
  • Mylan
  • Sandoz
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Budesonide (BUD) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Budesonide (BUD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Budesonide (BUD) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Budesonide (BUD) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Budesonide (BUD) Market Dynamics
  1. 2.1 Budesonide (BUD) Industry Trends
  2. 2.2 Budesonide (BUD) Industry Drivers
  3. 2.3 Budesonide (BUD) Industry Opportunities and Challenges
  4. 2.4 Budesonide (BUD) Industry Restraints
3 Budesonide (BUD) Market by Manufacturers
  1. 3.1 Global Budesonide (BUD) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Budesonide (BUD) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Budesonide (BUD) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Budesonide (BUD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Budesonide (BUD) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Budesonide (BUD) Manufacturers, Product Type & Application
  7. 3.7 Global Budesonide (BUD) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Budesonide (BUD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Budesonide (BUD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Budesonide (BUD) Tier 1, Tier 2, and Tier 3
4 Budesonide (BUD) Market by Type
  1. 4.1 Budesonide (BUD) Type Introduction
  2. 4.1.1 Pill
  3. 4.1.2 Inhaler
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Budesonide (BUD) Sales by Type
  6. 4.2.1 Global Budesonide (BUD) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Budesonide (BUD) Sales by Type (2021-2032)
  8. 4.2.3 Global Budesonide (BUD) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Budesonide (BUD) Revenue by Type
  10. 4.3.1 Global Budesonide (BUD) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Budesonide (BUD) Revenue by Type (2021-2032)
  12. 4.3.3 Global Budesonide (BUD) Revenue Market Share by Type (2021-2032)
5 Budesonide (BUD) Market by Application
  1. 5.1 Budesonide (BUD) Application Introduction
  2. 5.1.1 Nose Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Inflammatory Bowel Disease Treatment
  5. 5.2 Global Budesonide (BUD) Sales by Application
  6. 5.2.1 Global Budesonide (BUD) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Budesonide (BUD) Sales by Application (2021-2032)
  8. 5.2.3 Global Budesonide (BUD) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Budesonide (BUD) Revenue by Application
  10. 5.3.1 Global Budesonide (BUD) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Budesonide (BUD) Revenue by Application (2021-2032)
  12. 5.3.3 Global Budesonide (BUD) Revenue Market Share by Application (2021-2032)
6 Global Budesonide (BUD) Sales by Region
  1. 6.1 Global Budesonide (BUD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Budesonide (BUD) Sales by Region (2021-2032)
  3. 6.2.1 Global Budesonide (BUD) Sales by Region (2021-2026)
  4. 6.2.2 Global Budesonide (BUD) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Budesonide (BUD) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Budesonide (BUD) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Budesonide (BUD) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Budesonide (BUD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Budesonide (BUD) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Budesonide (BUD) Revenue by Region
  1. 7.1 Global Budesonide (BUD) Revenue by Region
  2. 7.1.1 Global Budesonide (BUD) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Budesonide (BUD) Revenue by Region (2021-2026)
  4. 7.1.3 Global Budesonide (BUD) Revenue by Region (2027-2032)
  5. 7.1.4 Global Budesonide (BUD) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Budesonide (BUD) Revenue (2021-2032)
  8. 7.2.2 North America Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Budesonide (BUD) Revenue (2021-2032)
  11. 7.3.2 Europe Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Budesonide (BUD) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Budesonide (BUD) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Budesonide (BUD) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chiesi Farmaceutici
  2. 8.1.1 Chiesi Farmaceutici Company Information
  3. 8.1.2 Chiesi Farmaceutici Business Overview
  4. 8.1.3 Chiesi Farmaceutici Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chiesi Farmaceutici Budesonide (BUD) Product Portfolio
  6. 8.1.5 Chiesi Farmaceutici Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Budesonide (BUD) Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Cosmo Pharmaceuticals
  14. 8.3.1 Cosmo Pharmaceuticals Company Information
  15. 8.3.2 Cosmo Pharmaceuticals Business Overview
  16. 8.3.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolio
  18. 8.3.5 Cosmo Pharmaceuticals Recent Developments
  19. 8.4 Dr. Falk Pharma
  20. 8.4.1 Dr. Falk Pharma Company Information
  21. 8.4.2 Dr. Falk Pharma Business Overview
  22. 8.4.3 Dr. Falk Pharma Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dr. Falk Pharma Budesonide (BUD) Product Portfolio
  24. 8.4.5 Dr. Falk Pharma Recent Developments
  25. 8.5 Lunan Better Pharmaceutical
  26. 8.5.1 Lunan Better Pharmaceutical Company Information
  27. 8.5.2 Lunan Better Pharmaceutical Business Overview
  28. 8.5.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolio
  30. 8.5.5 Lunan Better Pharmaceutical Recent Developments
  31. 8.6 Orion
  32. 8.6.1 Orion Company Information
  33. 8.6.2 Orion Business Overview
  34. 8.6.3 Orion Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Orion Budesonide (BUD) Product Portfolio
  36. 8.6.5 Orion Recent Developments
  37. 8.7 Shanghai Sine Promod Pharmaceutical
  38. 8.7.1 Shanghai Sine Promod Pharmaceutical Company Information
  39. 8.7.2 Shanghai Sine Promod Pharmaceutical Business Overview
  40. 8.7.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolio
  42. 8.7.5 Shanghai Sine Promod Pharmaceutical Recent Developments
  43. 8.8 Synmosa Biopharma
  44. 8.8.1 Synmosa Biopharma Company Information
  45. 8.8.2 Synmosa Biopharma Business Overview
  46. 8.8.3 Synmosa Biopharma Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Synmosa Biopharma Budesonide (BUD) Product Portfolio
  48. 8.8.5 Synmosa Biopharma Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Budesonide (BUD) Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Budesonide (BUD) Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Sandoz
  62. 8.11.1 Sandoz Company Information
  63. 8.11.2 Sandoz Business Overview
  64. 8.11.3 Sandoz Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sandoz Budesonide (BUD) Product Portfolio
  66. 8.11.5 Sandoz Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Budesonide (BUD) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Budesonide (BUD) Product Portfolio
  72. 8.12.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Budesonide (BUD) Value Chain Analysis
  2. 9.1.1 Budesonide (BUD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Budesonide (BUD) Production Mode & Process
  6. 9.2 Budesonide (BUD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Budesonide (BUD) Distributors
  9. 9.2.3 Budesonide (BUD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst